Dx Deals: Quest Closes PathAI Partial Acquisition and Strategic Alliance
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
Keeps You Up-to-Date on Lab Business and Competitive Strategy, Market Trends and Opportunities, and M&A and Investment Activity in Today’s Diagnostic Lab Industry
Deal is expected to give the lab giant a big boost in deploying artificial intelligence in the pathology space.
From - Laboratory Industry Report
Laboratory professionals will now have a new tool in the search for knowledge. The American Association for Clinical Chemistry, the NEJM Group, and Area9 Learning are joining forces to…
From - Laboratory Industry Report
Fourth quarter earnings reports are starting to trickle in. Here is a big picture roundup of some of the key results so far…
From - Laboratory Industry Report
In a month with an unusually heavy volume of diagnostic deal making, the headline story was Abbott Laboratories' $25 billion purchase of…
From - Laboratory Industry Report
Five major players in genetic testing have joined forces to promote cell-free DNA (cfDNA)-based noninvasive prenatal testing (NIPT). A newly formed organization…
From - Laboratory Industry Report
A notable FDA Section 510(k) approval was granted before the close of 2016 for Foundation Medicine's FoundationFocus CDxBRCA, a next-generation sequencing-based companion diagnostic test…
From - Diagnostic Testing & Emerging Technologies
Advanced diagnostic tests are emerging faster than the clinicians can document their clinical utility. All of this creates an interesting dilemma for…